Previous studies have identified many polymorphisms affecting multiple clock genes (BMAL1, CLOCK and NPAS2) that are linked to increased risks in prostate, breast, ovarian and pancreatic cancers [33, 34]. The gene discussed is BMAL1; the disease is pancreatic neoplasm.